Zetia: Targeted Cholesterol Management for LDL Reduction
Zetia
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.70 | $51.00 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $102.00 $82.00 (20%) | 🛒 Add to cart |
| 90 | $1.26 | $153.00 $113.00 (26%) | 🛒 Add to cart |
| 120 | $1.21 | $204.00 $145.00 (29%) | 🛒 Add to cart |
| 180 | $1.15 | $306.00 $207.00 (32%) | 🛒 Add to cart |
| 270 | $1.11 | $459.00 $301.00 (34%) | 🛒 Add to cart |
| 360 | $1.09
Best per pill | $612.00 $394.00 (36%) | 🛒 Add to cart |
Synonyms | |||
Zetia (ezetimibe) is a prescription medication specifically designed to lower elevated levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol. It operates through a unique mechanism of action, inhibiting cholesterol absorption in the small intestine, which complements other lipid-lowering strategies. As a non-statin therapy, it offers a valuable option for patients who require additional LDL reduction or cannot tolerate statin medications. Clinical evidence supports its efficacy in reducing cardiovascular risk when used as part of a comprehensive management plan under physician supervision.
Features
- Active ingredient: ezetimibe 10 mg per tablet
- Unique mechanism: selectively inhibits intestinal cholesterol absorption
- Available as oral tablet, with or without food
- Often used in combination with statin therapy for additive effect
- Manufactured under strict pharmaceutical quality standards
Benefits
- Significantly reduces LDL cholesterol levels by targeting intestinal absorption
- Provides an alternative or adjunct therapy for patients intolerant to statins
- Lowers non-HDL cholesterol and apolipoprotein B, key atherogenic particles
- May reduce cardiovascular event risk when combined with statin therapy
- Generally well-tolerated with a favorable safety profile in clinical studies
Common use
Zetia is indicated as adjunctive therapy to diet for the reduction of elevated LDL cholesterol in patients with primary hyperlipidemia, either alone or in combination with an HMG-CoA reductase inhibitor (statin). It is also used in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments. Additionally, it may be prescribed for patients with homozygous sitosterolemia to reduce elevated plant sterol levels. The medication is typically incorporated into a comprehensive treatment plan that includes therapeutic lifestyle modifications.
Dosage and direction
The recommended dosage of Zetia is 10 mg once daily, with or without food. It may be administered at any time of day, though consistency in timing is advised. When used in combination with a statin, Zetia may be administered simultaneously or separately. For patients with moderate to severe hepatic impairment, no dosage adjustment is necessary. In pediatric patients (10 years and older), the same 10 mg once daily dosage applies. The medication should be swallowed whole and not crushed or chewed.
Precautions
Patients should be advised that Zetia is not a substitute for cholesterol-lowering diet modifications. Liver function tests should be performed before initiation and during therapy according to clinical judgment. Patients should report any unexplained muscle pain, tenderness, or weakness promptly to their healthcare provider, particularly when used in combination with statins. Caution is advised in patients with moderate or severe hepatic impairment. Women of childbearing potential should use effective contraception during treatment.
Contraindications
Zetia is contraindicated in patients with known hypersensitivity to any component of the medication. It should not be used in combination with statins in patients with active liver disease or unexplained persistent elevations in hepatic transaminase levels. The medication is contraindicated in nursing women due to potential excretion in human milk. Concurrent use with cyclosporine is contraindicated due to significant increases in ezetimibe exposure.
Possible side effect
The most commonly reported adverse reactions (incidence ≥2% and greater than placebo) include: upper respiratory tract infection, diarrhea, arthralgia, sinusitis, and pain in extremity. Less common but potentially serious side effects may include: elevated hepatic transaminases, myopathy/rhabdomyolysis (particularly when used with statins), hypersensitivity reactions including angioedema and rash, and gastrointestinal disturbances. Pancreatitis and gallbladder disorders have been reported in post-marketing experience.
Drug interaction
Zetia may interact with several medications, including: cyclosporine (contraindicated due to significantly increased ezetimibe levels), fibrates (may increase risk of cholelithiasis), warfarin (monitor INR carefully), and cholestyramine (reduces ezetimibe absorption - administer至少 2 hours apart or 4 hours before). Concomitant use with other cholesterol-lowering agents requires careful monitoring for additive effects and potential adverse reactions.
Missed dose
If a dose is missed, patients should take it as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take double or extra doses to make up for a missed dose. Consistency in daily administration is important for maintaining stable cholesterol-lowering effects.
Overdose
In the event of overdose, supportive measures should be instituted as required. Ezetimibe is not dialyzable to a significant extent. In clinical studies, administration of ezetimibe at doses up to 50 mg/day to healthy volunteers for 14 days was generally well-tolerated. There is no specific antidote for ezetimibe overdose. Symptomatic and supportive treatment should be provided based on the patient’s clinical presentation.
Storage
Store Zetia tablets at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container with the lid tightly closed. Protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any unused medication according to local regulations.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Zetia is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should consult their physician for proper diagnosis and treatment recommendations. Individual results may vary, and not all patients will experience the same benefits or side effects. The full prescribing information should be reviewed before initiating therapy.
Reviews
Clinical trials have demonstrated that Zetia significantly reduces LDL cholesterol by approximately 18-20% when used as monotherapy and provides additional 25% reduction when added to statin therapy. Many physicians report positive experiences with Zetia as part of comprehensive lipid management, particularly in statin-intolerant patients. Patient reviews often note effective cholesterol reduction with generally good tolerability, though some report gastrointestinal side effects. The medication has maintained a favorable risk-benefit profile in post-marketing surveillance over many years of clinical use.